Loading...

Catalent, Inc.

CTLTNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$63.48
$0.00(0.00%)

Catalent, Inc. (CTLT) Stock Overview

Explore Catalent, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.5/100

Key Financials

Market Cap11.5B
P/E Ratio-27.97
EPS (TTM)$-2.28
ROE-0.11%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$60.70

CTLT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Catalent, Inc. (CTLT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $60.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.97 and a market capitalization of 11.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;